{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:15:38Z","timestamp":1791231338350,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,7,21]],"date-time":"2005-07-21T00:00:00Z","timestamp":1121904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1007\/s00262-005-0018-5","type":"journal-article","created":{"date-parts":[[2005,7,20]],"date-time":"2005-07-20T07:40:54Z","timestamp":1121845254000},"page":"451-458","source":"Crossref","is-referenced-by-count":117,"title":["Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients"],"prefix":"10.1007","volume":"55","author":[{"given":"J. B. A. G.","family":"Haanen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Baars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Weder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. D.","family":"de Gruijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. M. E.","family":"von Blomberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bloemena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Scheper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"van Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. M.","family":"Pinedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J. M.","family":"van den Eertwegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,7,21]]},"reference":[{"key":"18_CR1","first-page":"2665","volume":"20","author":"B Bodey","year":"2000","unstructured":"Bodey B, Bodey B Jr, Siegel SE, Kaiser HE (2000) Failure of cancer vaccines: the significant limitations of this approach to immunotherapy. Anticancer Res 20:2665\u20132676","journal-title":"Anticancer Res"},{"key":"18_CR2","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1200\/JCO.2002.01.151","volume":"20","author":"EC Hsueh","year":"2002","unstructured":"Hsueh EC, Essner R, Foshag LJ, Ollila DW, Gammon G, O\u2019Day SJ, Boasberg PD, Stern SL, Ye X, Morton DL (2002) Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine. J Clin Oncol 20:4549\u20134554","journal-title":"J Clin Oncol"},{"key":"18_CR3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/08830180305226","volume":"22","author":"EB Walker","year":"2003","unstructured":"Walker EB, Disis ML (2003) Monitoring immune responses in cancer patients receiving tumor vaccines. Int Rev Immunol 22:283\u2013319","journal-title":"Int Rev Immunol"},{"key":"18_CR4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00262-003-0473-9","volume":"53","author":"P Romero","year":"2004","unstructured":"Romero P, Cerottini JC, Speiser DE (2004) Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination. Cancer Immunol Immunother 53:249\u2013255","journal-title":"Cancer Immunol Immunother"},{"key":"18_CR5","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1023\/A:1008363601515","volume":"11","author":"A Baars","year":"2000","unstructured":"Baars A, Claessen AM, van den Eertwegh AJ, Gall HE, Stam AG, Meijer S, Giaccone G, Meijer CJ, Scheper RJ, Wagstaff J, Vermorken JB, Pinedo HM (2000) Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patients. Ann Oncol 11:965\u2013970","journal-title":"Ann Oncol"},{"key":"18_CR6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ijc.2910620118","volume":"62","author":"AB Bakker","year":"1995","unstructured":"Bakker AB, Schreurs MW, Tafazzul G, de Boer AJ, Kawakami Y, Adema GJ, Figdor CG (1995) Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line. Int J Cancer 62:97\u2013102","journal-title":"Int J Cancer"},{"key":"18_CR7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1084\/jem.180.1.347","volume":"180","author":"Y Kawakami","year":"1994","unstructured":"Kawakami Y, Eliyahu S, Sakaguchi K, Robbins PF, Rivoltini L, Yannelli JR, Appella E, Rosenberg SA (1994) Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 180:347\u2013352","journal-title":"J Exp Med"},{"key":"18_CR8","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.4049\/jimmunol.154.8.3961","volume":"154","author":"Y Kawakami","year":"1995","unstructured":"Kawakami Y, Eliyahu S, Jennings C, Sakaguchi K, Kang X, Southwood S, Robbins PF, Sette A, Appella E, Rosenberg SA (1995) Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J Immunol 154:3961\u20133968","journal-title":"J Immunol"},{"key":"18_CR9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00002371-200001000-00004","volume":"23","author":"Y Kawakami","year":"2000","unstructured":"Kawakami Y, Dang N, Wang X, Tupesis J, Robbins PF, Wang RF, Wunderlich JR, Yannelli JR, Rosenberg SA (2000) Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma. J Immunother 23:17\u201327","journal-title":"J Immunother"},{"key":"18_CR10","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.4049\/jimmunol.157.11.5027","volume":"157","author":"JC Skipper","year":"1996","unstructured":"Skipper JC, Kittlesen DJ, Hendrickson RC, Deacon DD, Harthun NL, Wagner SN, Hunt DF, Engelhard VH, Slingluff CL Jr (1996) Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17\/gp100. J Immunol 157:5027\u20135033","journal-title":"J Immunol"},{"key":"18_CR11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/eji.1830240340","volume":"24","author":"T Wolfel","year":"1994","unstructured":"Wolfel T, Van Pel A, Brichard V, Schneider J, Seliger B, Meyer zum Buschenfelde KH, Boon T (1994) Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur J Immunol 24:759\u2013764","journal-title":"Eur J Immunol"},{"key":"18_CR12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/1523-1747.ep12298177","volume":"107","author":"H Zarour","year":"1996","unstructured":"Zarour H, De Smet C, Lehmann F, Marchand M, Lethe B, Romero P, Boon T, Renauld JC (1996) The majority of autologous cytolytic T-lymphocyte clones derived from peripheral blood lymphocytes of a melanoma patient recognize an antigenic peptide derived from gene Pmel17\/gp100. J Invest Dermatol 107:63\u201367","journal-title":"J Invest Dermatol"},{"key":"18_CR13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1084\/jem.190.5.651","volume":"190","author":"A Anichini","year":"1999","unstructured":"Anichini A, Molla A, Mortarini R, Tragni G, Bersani I, Di Nicola M, Gianni AM, Pilotti S, Dunbar R, Cerundolo V, Parmiani G (1999) An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions. J Exp Med 190:651\u2013667","journal-title":"J Exp Med"},{"key":"18_CR14","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.4049\/jimmunol.165.11.6644","volume":"165","author":"PR Dunbar","year":"2000","unstructured":"Dunbar PR, Smith CL, Chao D, Salio M, Shepherd D, Mirza F, Lipp M, Lanzavecchia A, Sallusto F, Evans A, Russell-Jones R, Harris AL, Cerundolo V (2000) A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response. J Immunol 165:6644\u20136652","journal-title":"J Immunol"},{"key":"18_CR15","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1158\/0008-5472.CAN-03-3066","volume":"64","author":"A Zippelius","year":"2004","unstructured":"Zippelius A, Batard P, Rubio-Godoy V, Bioley G, Lienard D, Lejeune F, Rimoldi D, Guillaume P, Meidenbauer N, Mackensen A, Rufer N, Lubenow N, Speiser D, Cerottini JC, Romero P, Pittet MJ (2004) Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance. Cancer Res 64:2865\u20132873","journal-title":"Cancer Res"},{"key":"18_CR16","doi-asserted-by":"crossref","unstructured":"van Oijen M, Bins A, Elias S, Sein J, Weder P, de Gast GC, Mallo H, Gallee M, van Tinteren H, Schumacher TN, Haanen JB (2004) On the role of melanoma-specific CD8+ T cell immunity in disease progression of advanced-stage melanoma patients. Clin Cancer Res 10:4754\u20134760","DOI":"10.1158\/1078-0432.CCR-04-0260"},{"key":"18_CR17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.274.5284.94","volume":"274","author":"JD Altman","year":"1996","unstructured":"Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94\u201396","journal-title":"Science"},{"key":"18_CR18","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.4049\/jimmunol.160.4.1750","volume":"160","author":"D Valmori","year":"1998","unstructured":"Valmori D, Fonteneau JF, Lizana CM, Gervois N, Lienard D, Rimoldi D, Jongeneel V, Jotereau F, Cerottini JC, Romero P (1998) Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A\/MART-1 immunodominant peptide analogues. J Immunol 160:1750\u20131758","journal-title":"J Immunol"},{"key":"18_CR19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.183.2.527","volume":"183","author":"JC Skipper","year":"1996","unstructured":"Skipper JC, Hendrickson RC, Gulden PH, Brichard V, Van Pel A, Chen Y, Shabanowitz J, Wolfel T, Slingluff CL Jr, Boon T, Hunt DF, Engelhard VH (1996) An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J Exp Med 183:527\u2013534","journal-title":"J Exp Med"},{"key":"18_CR20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1084\/jem.187.1.37","volume":"187","author":"CA Mosse","year":"1998","unstructured":"Mosse CA, Meadows L, Luckey CJ, Kittlesen DJ, Huczko EL, Slingluff CL, Shabanowitz J, Hunt DF, Engelhard VH (1998) The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J Exp Med 187:37\u201348","journal-title":"J Exp Med"},{"key":"18_CR21","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.4049\/jimmunol.163.5.2928","volume":"163","author":"P Chaux","year":"1999","unstructured":"Chaux P, Luiten R, Demotte N, Vantomme V, Stroobant V, Traversari C, Russo V, Schultz E, Cornelis GR, Boon T, van der Bruggen P (1999) Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1. J Immunol 163:2928\u20132936","journal-title":"J Immunol"},{"key":"18_CR22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ijc.1580","volume":"97","author":"MJ Maeurer","year":"2002","unstructured":"Maeurer MJ, Necker A, Salter RD, Castelli C, Hohn H, Karbach J, Freitag K, Neukirch C, Knuth A, Jager E (2002) Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A\/Mart-1 peptide analogue. Int J Cancer 97:64\u201371","journal-title":"Int J Cancer"},{"key":"18_CR23","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.4049\/jimmunol.163.8.4342","volume":"163","author":"JA Whelan","year":"1999","unstructured":"Whelan JA, Dunbar PR, Price DA, Purbhoo MA, Lechner F, Ogg GS, Griffiths G, Phillips RE, Cerundolo V, Sewell AK (1999) Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent. J Immunol 163:4342\u20134348","journal-title":"J Immunol"},{"key":"18_CR24","first-page":"3932","volume":"61","author":"K Schumacher","year":"2001","unstructured":"Schumacher K, Haensch W, Roefzaad C, Schlag PM (2001) Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. Cancer Res 61:3932\u20133936","journal-title":"Cancer Res"},{"key":"18_CR25","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/0959-8049(94)E0159-2","volume":"30","author":"S Vesalainen","year":"1994","unstructured":"Vesalainen S, Lipponen P, Talja M, Syrjanen K (1994) Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer 30A:1797\u20131803","journal-title":"Eur J Cancer"},{"key":"18_CR26","first-page":"3491","volume":"58","author":"Y Naito","year":"1998","unstructured":"Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H (1998) CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58:3491\u20133494","journal-title":"Cancer Res"},{"key":"18_CR27","first-page":"5132","volume":"61","author":"O Nakano","year":"2001","unstructured":"Nakano O, Sato M, Naito Y, Suzuki K, Orikasa S, Aizawa M, Suzuki Y, Shintaku I, Nagura H, Ohtani H (2001) Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res 61:5132\u20135136","journal-title":"Cancer Res"},{"key":"18_CR28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","volume":"348","author":"L Zhang","year":"2003","unstructured":"Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348:203\u2013213","journal-title":"N Engl J Med"},{"key":"18_CR29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/(SICI)1097-0215(19971021)74:5<492::AID-IJC3>3.0.CO;2-Z","volume":"74","author":"AJ Marrogi","year":"1997","unstructured":"Marrogi AJ, Munshi A, Merogi AJ, Ohadike Y, El-Habashi A, Marrogi OL, Freeman SM (1997) Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma. Int J Cancer 74:492\u2013501","journal-title":"Int J Cancer"},{"key":"18_CR30","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","volume":"77","author":"CG Clemente","year":"1996","unstructured":"Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N (1996) Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 77:1303\u20131310","journal-title":"Cancer"},{"key":"18_CR31","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1084\/jem.188.9.1641","volume":"188","author":"P Romero","year":"1998","unstructured":"Romero P, Dunbar PR, Valmori D, Pittet M, Ogg GS, Rimoldi D, Chen JL, Lienard D, Cerottini JC, Cerundolo V (1998) Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J Exp Med 188:1641\u20131650","journal-title":"J Exp Med"},{"key":"18_CR32","first-page":"909s","volume":"7","author":"G Yamshchikov","year":"2001","unstructured":"Yamshchikov G, Thompson L, Ross WG, Galavotti H, Aquila W, Deacon D, Caldwell J, Patterson JW, Hunt DF, Slingluff CL Jr (2001) Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations. Clin Cancer Res 7:909s\u201316s","journal-title":"Clin Cancer Res"},{"key":"18_CR33","first-page":"685","volume":"3","author":"GA Waanders","year":"1997","unstructured":"Waanders GA, Rimoldi D, Lienard D, Carrel S, Lejeune F, Dietrich PY, Cerottini JC, Romero P (1997) Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line. Clin Cancer Res 3:685\u2013696","journal-title":"Clin Cancer Res"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-005-0018-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-005-0018-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-005-0018-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T19:46:56Z","timestamp":1683143216000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-005-0018-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,21]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["18"],"URL":"https:\/\/doi.org\/10.1007\/s00262-005-0018-5","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,21]]}}}